Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis

S.J. Clarke; S. Yip; C. Brown; Guy Van Hazel; D.T. Ransom; D. Goldstein; G.M. Jeffrey; N.C. Tebbutt; M. Buck; R.M. Lowenthal; A. Boland; V. Gebski; J. Zalcberg; R.J. Simes

doi:10.1016/j.ejca.2011.04.024

Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis

S.J. Clarke, S. Yip, C. Brown, Guy Van Hazel, D.T. Ransom, D. Goldstein, G.M. Jeffrey, N.C. Tebbutt, M. Buck, R.M. Lowenthal, A. Boland, V. Gebski, J. Zalcberg, R.J. Simes

Research output: Contribution to journal › Article › peer-review

15 Citations (Scopus)

Original language	English
Pages (from-to)	1826-1836
Journal	European Journal of Cancer
Volume	47
DOIs	https://doi.org/10.1016/j.ejca.2011.04.024
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2011.04.024

Cite this

Clarke, S. J., Yip, S., Brown, C., Van Hazel, G., Ransom, D. T., Goldstein, D., Jeffrey, G. M., Tebbutt, N. C., Buck, M., Lowenthal, R. M., Boland, A., Gebski, V., Zalcberg, J., & Simes, R. J. (2011). Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis. European Journal of Cancer, 47, 1826-1836. https://doi.org/10.1016/j.ejca.2011.04.024

@article{63d937ffdaea46ad9b8cebe1817ff75a,

title = "Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis",

author = "S.J. Clarke and S. Yip and C. Brown and {Van Hazel}, Guy and D.T. Ransom and D. Goldstein and G.M. Jeffrey and N.C. Tebbutt and M. Buck and R.M. Lowenthal and A. Boland and V. Gebski and J. Zalcberg and R.J. Simes",

year = "2011",

doi = "10.1016/j.ejca.2011.04.024",

language = "English",

volume = "47",

pages = "1826--1836",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier",

}

Clarke, SJ, Yip, S, Brown, C, Van Hazel, G, Ransom, DT, Goldstein, D, Jeffrey, GM, Tebbutt, NC, Buck, M, Lowenthal, RM, Boland, A, Gebski, V, Zalcberg, J & Simes, RJ 2011, 'Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis', European Journal of Cancer, vol. 47, pp. 1826-1836. https://doi.org/10.1016/j.ejca.2011.04.024

TY - JOUR

T1 - Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis

AU - Clarke, S.J.

AU - Yip, S.

AU - Brown, C.

AU - Van Hazel, Guy

AU - Ransom, D.T.

AU - Goldstein, D.

AU - Jeffrey, G.M.

AU - Tebbutt, N.C.

AU - Buck, M.

AU - Lowenthal, R.M.

AU - Boland, A.

AU - Gebski, V.

AU - Zalcberg, J.

AU - Simes, R.J.

PY - 2011

Y1 - 2011

U2 - 10.1016/j.ejca.2011.04.024

DO - 10.1016/j.ejca.2011.04.024

M3 - Article

C2 - 21665462

VL - 47

SP - 1826

EP - 1836

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -